Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.080
-0.050 (-4.42%)
At close: Apr 1, 2025, 4:00 PM
1.090
+0.010 (0.93%)
After-hours: Apr 1, 2025, 4:41 PM EDT

Rockwell Medical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of 4.00, with a low estimate of 3.00 and a high estimate of 5.00. The average target predicts an increase of 270.37% from the current stock price of 1.08.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3.00 $4.00 $5.00 $5.00
Change +177.78% +270.37% +362.96% +362.96%

Analyst Ratings

The average analyst rating for Rockwell Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$3
Strong Buy Maintains $7$3 +177.78% Mar 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +548.15% Dec 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$9$7
Strong Buy Maintains $9$7 +548.15% Nov 25, 2024
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +362.96% Nov 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$9
Strong Buy Reiterates $9 +733.33% Sep 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
68.77M
from 101.49M
Decreased by -32.24%
Revenue Next Year
75.94M
from 68.77M
Increased by 10.42%
EPS This Year
-0.13
from -0.03
EPS Next Year
-0.21
from -0.13
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
62.20M61.93M72.81M83.61M101.49M68.77M75.94M
Revenue Growth
1.46%-0.43%17.57%14.84%21.38%-32.24%10.42%
EPS
-4.49-3.83-1.31-0.37-0.03-0.13-0.21
EPS Growth
-------
Forward PE
-------
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 73.3M 84.6M
Avg 68.8M 75.9M
Low 63.7M 66.9M

Revenue Growth

Revenue Growth 20252026
High
-27.8%
23.1%
Avg
-32.2%
10.4%
Low
-37.2%
-2.7%

EPS Forecast

EPS 20252026
High -0.03 -0.22
Avg -0.13 -0.21
Low -0.23 -0.21

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.